Neuraxis, Inc (NRXS): Cash & Equivalents

Annual figures by period end, from SEC filings.

$4.97M
As of 2025-12-31
$8.32M
As of 2026-06-30
+169.5%
3-year compound annual growth
2022-12-31: $253.7K2023-09-30: $761.2K2023-12-31: $78.6K2024-12-31: $3.70M2025-12-31: $4.97M$4.97M
2022-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$4.97M+34.3%2026-03-19, Balance as of period end
2024-12-31$3.70Mn/m2026-03-19, Balance as of period end
2023-12-31$78.6Kn/a2025-03-20, Balance as of period end
2023-09-30$761.2Kn/a2024-04-16, Balance as of period end
2022-12-31$253.7Kn/a2024-04-16, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Neuraxis, Inc (NRXS)2025-12-31$4.97M+34.3%
ADM Tronics Unlimited, Inc. (ADMT)2026-03-31$255.7K-33.2%
Nuwellis, Inc. (NUWE)2025-12-31$1.08M-78.7%
Escalon Medical Corp (ESMC)2025-06-30$545.8K+161.1%
Hyperfine, Inc. (HYPR)2025-12-31$35.09M-6.8%
QT Imaging Holdings, Inc. (QTI)2025-12-31$10.41M+788.4%
Precision Optics Corporation, Inc. (POCI)2025-06-30$1.77M+337.7%
iTonic Holdings Ltd (ITOC)2025-12-31$1.49M-75.8%
electroCore, Inc. (ECOR)2025-12-31$7.04M+90.1%

Compare NRXS, ADMT, NUWE, ESMC side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗